Kalashnikova L A, Legenko M S, Shabalina A A, Dobrynina L A, Shamtieva K V, Kostyreva M V, Dreval M V, Lesnykh T A
Research Center of Neurology, Moscow, Russia.
Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(7):14-21. doi: 10.17116/jnevro202112107114.
To study clinical/laboratory signs of primary vasculitis (PV) of the internal carotid artery (ICA) and vertebral artery (VA).
We examined 31 patients (23 men, 74%, mean age - 36.2±5.7 years) with ICA/VA PV verified by vessel wall contrast enhancement on black blood MRI (T1-weighted fat and blood suppressed sequences with- and without contrast injection) at the Research Center of Neurology (Moscow) from January 2012 to September 2019. Systemic vasculitis was excluded in all cases. Interleukins (IL-1β, IL-2, IL-6, IL-17), TNF-a, transforming growth factor beta 1 (TGF-β1) and basic fibroblast growth factor (bFGF) were analyzed by ELISA in 25 patients. Control group consisted of 21 healthy volunteers (12 men, 57%; mean age - 35.3±10.2 years).
Clinical manifestations of ICA/VA PV included: ischemic stroke (IS) (94%), which combined with transient ischemic attacks (TIA) in 35%; isolated TIA (3%); Tolosa-Hunt syndrome (3%). Recurrent strokes were observed in 41% of patients on average in 5.3±2.1 months. Carotid artery was involved in 77%, VA - in 16%, both arteries - in 7%. Concomitant involvement of ICA/VA branches was in 19% patients. The level of arterial damage was follows: Intracranial part of arteries involved in 55%, intra-extracranial - in 35%, extracranial - in 10%. Bilateral involvement was found in 26%. Headache/neck pain in the acute IS period was observed in 21%. IS severity (NIHSS) was as follows: moderate (59%), mild (34%), moderately severe (7%). Disability after 3 months according to mRankin scale was as follows: mild (72%) moderate (21%), none (7%). The laboratory study revealed an increased levels of IL-6 (8.19±3.89 pg/ml vs 4.7±1.48 in control, =0.000), IL-2 (5.64±1.82 pg/ml vs 4.30±1.65, =0.013), TNF-a (36.9±33.66 pg/ml vs 12.68±5.93, =0.000), TGF β1 (2.77±1.60 pg/ml vs 1.63±0.64, =0.006) and bFGF (417.67±132.68 pg/ml vs 335.71±105.08, =0.018). The levels of IL-1β and IL-17 did not differ significantly from the control.
ICA/VA PV has a number of clinical peculiarities. Proinflammatory cytokines produced by Th17 and Th1 CD4+ lymphocytes as well as bFGF and TGR-β1 play a role in its pathogenesis. Normal levels of IL-1β and IL-17 suggest that they are not significant in the development of isolated inflammation in ICA/PA, in contrast to systemic inflammation in giant cell arteritis, in which, according to literature data, their level increases. Isolated ICA/PA inflammation seems to be caused by transaxonal (trigeminal nerve, upper-cervical roots, autonomic nerves) spread of pathogens that initiate immune inflammation in the ICA/PA wall.
研究颈内动脉(ICA)和椎动脉(VA)原发性血管炎(PV)的临床/实验室特征。
我们对2012年1月至2019年9月在莫斯科神经病学研究中心通过黑血磁共振成像(T1加权脂肪和血液抑制序列,注射对比剂前后)血管壁对比增强证实患有ICA/VA PV的31例患者(23例男性,占74%,平均年龄 - 36.2±5.7岁)进行了检查。所有病例均排除系统性血管炎。对25例患者采用酶联免疫吸附测定法分析白细胞介素(IL-1β、IL-2、IL-6、IL-17)、肿瘤坏死因子-α(TNF-α)、转化生长因子β1(TGF-β1)和碱性成纤维细胞生长因子(bFGF)。对照组由21名健康志愿者组成(12例男性,占57%;平均年龄 - 35.3±10.2岁)。
ICA/VA PV的临床表现包括:缺血性卒中(IS)(94%),其中35%合并短暂性脑缺血发作(TIA);孤立性TIA(3%);托洛萨-亨特综合征(3%)。平均41%的患者在5.3±2.1个月内出现复发性卒中。颈动脉受累占77%,椎动脉受累占16%,双侧动脉受累占7%。19%的患者伴有ICA/VA分支受累。动脉损伤程度如下:颅内段动脉受累占55%,颅内外段占35%,颅外段占10%。26%的患者为双侧受累。21%的患者在急性IS期出现头痛/颈部疼痛。IS严重程度(美国国立卫生研究院卒中量表)如下:中度(59%)、轻度(34%)、中度严重(7%)。根据改良Rankin量表,3个月后残疾情况如下:轻度(72%)、中度(21%)、无残疾(7%)。实验室研究显示IL-6(8.19±3.89 pg/ml,对照组为4.7±1.48,P = 0.000)、IL-2(5.64±1.82 pg/ml,对照组为4.30±1.65,P = 0.